Transfusion Support for Patients with Sickle Cell Disease, 2nd Edition
By MD Jennifer Andrews, MD, MSc, and Marisa B. Marques
Affecting millions around the world, sickle cell disease (SCD) in the United States disproportionately affects African Americans and Hispanic Americans at a rate of 1 in 365 or 16,300 births, respectively. Since the first edition of this book more than 20 years ago, significant advances have made this is a truly exciting time with new therapies and curative options. Transfusion remains a critical tool in the therapeutic armamentarium, and this book offers the most recent research and best clinical practices from leading experts, including something for everyone involved in the treatment of SCD patients-clinicians, laboratory staff, and administrators. Eleven chapters cover the following broad topic areas: Foundational pathology of SCD Indications and best approaches for transfusion, from simple transfusions to isovolemic exchange procedures Alloimmunization and the use of molecular diagnostics Other complications of SCD and of transfusion Pragmatic clinical and coordinated laboratory model of best care Stem cell and other cellular therapies
Sickle cell disease (SCD) is a genetic disorder that affects millions of people around the world, with a particularly high prevalence among African Americans and Hispanic Americans. In the United States alone, SCD affects approximately 1 in 365 or 16,300 births of these populations. The impact of this disease on individuals and their families is profound, and finding effective treatments and interventions is of utmost importance.
In the last two decades, significant advancements have been made in the understanding and management of SCD. Exciting new therapies and curative options have emerged, making this an unprecedented time in the field. Among the critical tools in the treatment of SCD is transfusion, which plays a vital role in managing the complications and improving the quality of life for patients.
For those involved in the treatment of SCD patients, whether clinicians, laboratory staff, or administrators, the book “Transfusion Medicine and Sickle Cell Disease” is an invaluable resource. Written by leading experts in the field, this book combines the latest research with best clinical practices, offering comprehensive insights into the foundational pathology of SCD, indications for transfusion, complications of SCD and transfusion, and emerging therapies.
The book begins by providing a solid understanding of the pathology of SCD, laying the groundwork for subsequent chapters. It then delves into the indications and best approaches for transfusion, covering everything from simple transfusions to isovolemic exchange procedures. The use of molecular diagnostics for alloimmunization, a common complication of transfusion in SCD patients, is explored in detail, providing a comprehensive understanding of this phenomenon.
Additionally, the book covers other complications of both SCD and transfusion, addressing the challenges that clinicians and patients face beyond the need for transfusion. It highlights the importance of a pragmatic clinical and coordinated laboratory model of care, emphasizing the value of collaboration and teamwork in achieving the best outcomes for patients.
One of the most exciting areas of research and treatment in SCD is stem cell and other cellular therapies. The book includes a dedicated chapter that explores these emerging therapies, providing valuable insights into their potential and current applications.
With 292 pages, the book offers a wealth of knowledge and expertise in the field of transfusion medicine and SCD. Published by the American Association of Blood Banks, a trusted authority in the field, this book ensures that readers have access to the most up-to-date information and recommendations.
From a practical standpoint, “Transfusion Medicine and Sickle Cell Disease” offers a clear and concise guide to implementing best practices in the management of SCD patients. It provides evidence-based strategies and recommendations that can be readily applied in clinical settings, benefiting both healthcare professionals and the patients they serve.
The book is authored by MD Jennifer Andrews, MD, MSc, and Marisa B. Marques, who are experts in the field of transfusion medicine and have extensive experience in treating patients with SCD. Their expertise and insights make this book a must-have resource for anyone involved in the care of SCD patients.
Ordering the book “Transfusion Medicine and Sickle Cell Disease” is a decision that will undoubtedly provide immense value for clinicians, laboratory staff, and administrators involved in the treatment of SCD patients. Whether you are seeking to expand your knowledge in the field or looking for practical guidance in your day-to-day practice, this book offers a comprehensive and authoritative resource.
By staying up-to-date with the latest research and best clinical practices, you can provide the best care for SCD patients, improving their quality of life and potentially even contributing to the advancement of curative options. Don’t miss out on the opportunity to enhance your understanding and make a difference in the lives of those affected by SCD – order your copy of “Transfusion Medicine and Sickle Cell Disease” today.
Product Details
- Publisher : American Association of Blood Banks (January 1, 2022)
- : 292 pages
- ISBN-10 : 1563954478
- ISBN-13 : 978-1563954474